Publications by authors named "Carla Maria Boquimpani"
Inclusion of molecular monitoring (BCR-ABL1) in the treatment of chronic myeloid leukemia in the Brazilian Public Health System (SUS): an urgent need for treatment management.
Carla Maria Boquimpani André Neder Ramires Abdo Denise Pires Martins Luciana Britto de Abreu Lima Mayde Seadi Torriani
Hematol Transfus Cell Ther
May 2020
Article Synopsis
- - Chronic Myeloid Leukemia (CML) predominantly affects adults aged 50 to 55; in 2017, over 12,000 patients in Brazil received outpatient treatment approval for CML despite the lack of reimbursements for necessary monitoring tests like quantitative PCR.
- - Effective monitoring through molecular response evaluation is vital for optimal CML patient care, enabling timely interventions and even possible treatment discontinuation for suitable cases.
- - Expert recommendations emphasize the urgent need for funding and reimbursement for molecular testing in SUS, highlighting potential cost savings from reduced medication usage when patients are closely monitored.